Billionaires Reduce Holdings in UnitedHealth, Yet Wall Street Remains Bullish May 28, 2026 Life Science
Translating 10 Projects Weekly, Eli Lilly Launches Largest Acquisition Wave in Its History May 26, 2026 Life Science
Beyond Lilly and Novo Nordisk: Two Under-the-Radar Picks in the Obesity Drug Market May 26, 2026 Life Science
Is Pfizer’s Stock, with a Dividend Yield Exceeding 6%, Undervalued by the Market? May 25, 2026 Life Science
These Three Disruptive Stocks Are Poised to Deliver Massive Returns Over the Next Two Decades May 25, 2026 Life Science, Technology
Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley May 25, 2026 Life Science
Strong Performance in Healthcare Sector Driven by Multiple Positive Factors May 22, 2026 Life Science
Pfizer’s 50% Stock Crash: A Hidden Contrarian Buy Amid Booming Healthcare Sector May 22, 2026 Life Science
Three Recession-Resistant Stocks Worth Investors’ Attention May 22, 2026 Consumer Goods, Life Science
The Market Underestimates Bristol-Myers Squibb’s New Product Growth Potential May 21, 2026 Life Science
Can Viking Therapeutics Replicate Eli Lilly’s Success in the Weight-Loss Drug Market? May 21, 2026 Life Science
CVS Health Stock Rallies 24% in a Month as Business Turnback Fuels Rebound May 20, 2026 Financial Service, Life Science
Dyne Therapeutics Stock Rises 40% in a Year, but Saturn V Fund Reduces Holdings May 20, 2026 Life Science
These Two Healthcare Giants Set for Fresh Dividend Hikes, Ideal Time to Invest May 19, 2026 Life Science
Can Novo Nordisk Stage a Turnaround on Wegovy Data and Robust Drug Pipeline? May 13, 2026 Life Science
